Overactive Bladder Market Report

China Overactive Bladder Industry Market Research Report 2023-2029

  • POSTDATE：Sep 04, 2023
  • PAGES：185
  • REPORT CODE：GMM1776645
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Overactive Bladder industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Bayer

    • Laboratorios SALVAT

    • Apogepha Arzneimittel

    • GlaxoSmithKline

    • Lipella Pharmaceuticals

    • Ferring Pharmaceuticals

    • Merck

    • Kwang Dong Pharmaceutical

    • TARIS BioMedical

    • Elbion

    • Ranbaxy Laboratories

    • Ono Pharmaceuticals

    • Mylan

    • Urigen Pharmaceuticals

    • Motif BioSciences

    • Sanofi

    • Recordati

    • Ion Channel Innovations

    • Addex Therapeutics

    • Auxilium Pharmaceuticals

    • FemmePharma

    • Kissei Pharma

    • Allergan

    • AltheRx Pharmaceuticals

    • Hydra Biosciences

    • Janssen

    • Antares Pharma

    • Pfizer

    • TheraVida

    • LG Life Sciences

    • Hisamitsu Pharmaceutical

    • Actavis

    • Toray Industries

    • Ipsen

    • Novartis

    • Teva Pharmaceutical

    • Takeda Pharmaceutical

    By Type:

    • Type 1

    • Type 2

    • Type 3

    By Application:

    • Application 1

    • Application 2

    • Application 3

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Overactive Bladder Market Overview 2018-2029

    • 1.1 China Overactive Bladder Industry Development Overview

    • 1.2 China Overactive Bladder Industry Development History

    • 1.3 China Overactive Bladder Industry Market Size (2018-2029)

    • 1.4 China Overactive Bladder Market Analysis by Type from Production Side

      • 1.4.1 China Overactive Bladder Production Volume, Production Value and Growth Rate of Type 1 (2018-2029)

      • 1.4.2 China Overactive Bladder Production Volume, Production Value and Growth Rate of Type 2 (2018-2029)

      • 1.4.3 China Overactive Bladder Production Volume, Production Value and Growth Rate of Type 3 (2018-2029)

    • 1.5 China Overactive Bladder Market Analysis by Application from Consumption End

      • 1.5.1 China Overactive Bladder Sales Volume, Sales Value and Growth Rate of Application 1 (2018-2029)

      • 1.5.2 China Overactive Bladder Sales Volume, Sales Value and Growth Rate of Application 2 (2018-2029)

      • 1.5.3 China Overactive Bladder Sales Volume, Sales Value and Growth Rate of Application 3 (2018-2029)

    • 1.6 China Overactive Bladder Market Analysis by Region

      • 1.6.1 North China Overactive Bladder Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Overactive Bladder Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Overactive Bladder Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Overactive Bladder Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Overactive Bladder Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Overactive Bladder Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Overactive Bladder Market Size and Growth Rate from 2018-2029

    Chapter 2 China Overactive Bladder Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Overactive Bladder Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Overactive Bladder Market Status and Competition Analysis in 2023

      • 2.2.3 China Overactive Bladder Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Overactive Bladder Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Overactive Bladder Industry Development

    Chapter 3 Overactive BladderIndustry Chain Analysis

    • 3.1 Overactive Bladder Industry Chain

    • 3.2 Overactive Bladder Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Overactive Bladder Market

    • 3.3 Overactive Bladder Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Overactive Bladder Market

    Chapter 4 China Overactive Bladder Market, by Type

    • 4.1 China Overactive Bladder Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Overactive Bladder Total Production Volume and Growth Rate from Production Side

    • 4.5 China Overactive Bladder Production Volume and Growth Rate, by Type

      • 4.5.1 China Overactive Bladder Production Volume and Growth Rate of Type 1

      • 4.5.2 China Overactive Bladder Production Volume and Growth Rate of Type 2

      • 4.5.3 China Overactive Bladder Production Volume and Growth Rate of Type 3

    Chapter 5 China Overactive Bladder Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Overactive Bladder Total Market Size and Growth Rate from Consumption End

    • 5.5 China Overactive Bladder Market Size and Growth Rate, by Application

      • 5.5.1 China Overactive Bladder Market Size and Growth Rate of Application 1

      • 5.5.2 China Overactive Bladder Market Size and Growth Rate of Application 2

      • 5.5.3 China Overactive Bladder Market Size and Growth Rate of Application 3

    Chapter 6 China Overactive Bladder Market, by Region

    • 6.1 China Overactive Bladder Production Volume and Production Value, by Region

    • 6.2 China Overactive Bladder Sales Volume and Sales Value, by Region

    Chapter 7 North China Overactive Bladder Market Analysis

    • 7.1 North China Overactive Bladder Market, by Type

    • 7.2 North China Overactive Bladder Market, by Application

    Chapter 8 Central China Overactive Bladder Market Analysis

    • 8.1 Central China Overactive Bladder Market, by Type

    • 8.2 Central China Overactive Bladder Market, by Application

    Chapter 9 South China Overactive Bladder Market Analysis

    • 9.1 South China Overactive Bladder Market, by Type

    • 9.2 South China Overactive Bladder Market, by Application

    Chapter 10 East China Overactive Bladder Market Analysis

    • 10.1 East China Overactive Bladder Market, by Type

    • 10.2 East China Overactive Bladder Market, by Application

    Chapter 11 Northeast China Overactive Bladder Market Analysis

    • 11.1 Northeast China Overactive Bladder Market, by Type

    • 11.2 Northeast China Overactive Bladder Market, by Application

    Chapter 12 Southwest China Overactive Bladder Market Analysis

    • 12.1 Southwest China Overactive Bladder Market, by Type

    • 12.2 Southwest China Overactive Bladder Market, by Application

    Chapter 13 Northwest China Overactive Bladder Market Analysis

    • 13.1 Northwest China Overactive Bladder Market, by Type

    • 13.2 Northwest China Overactive Bladder Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Bayer

        • 14.1.1 Bayer Company Profile

        • 14.1.2 Bayer Overactive Bladder Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Laboratorios SALVAT

        • 14.2.1 Laboratorios SALVAT Company Profile

        • 14.2.2 Laboratorios SALVAT Overactive Bladder Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Apogepha Arzneimittel

        • 14.3.1 Apogepha Arzneimittel Company Profile

        • 14.3.2 Apogepha Arzneimittel Overactive Bladder Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 GlaxoSmithKline

        • 14.4.1 GlaxoSmithKline Company Profile

        • 14.4.2 GlaxoSmithKline Overactive Bladder Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Lipella Pharmaceuticals

        • 14.5.1 Lipella Pharmaceuticals Company Profile

        • 14.5.2 Lipella Pharmaceuticals Overactive Bladder Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Ferring Pharmaceuticals

        • 14.6.1 Ferring Pharmaceuticals Company Profile

        • 14.6.2 Ferring Pharmaceuticals Overactive Bladder Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Merck

        • 14.7.1 Merck Company Profile

        • 14.7.2 Merck Overactive Bladder Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Kwang Dong Pharmaceutical

        • 14.8.1 Kwang Dong Pharmaceutical Company Profile

        • 14.8.2 Kwang Dong Pharmaceutical Overactive Bladder Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 TARIS BioMedical

        • 14.9.1 TARIS BioMedical Company Profile

        • 14.9.2 TARIS BioMedical Overactive Bladder Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 Elbion

        • 14.10.1 Elbion Company Profile

        • 14.10.2 Elbion Overactive Bladder Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 Ranbaxy Laboratories

        • 14.11.1 Ranbaxy Laboratories Company Profile

        • 14.11.2 Ranbaxy Laboratories Overactive Bladder Market Performance

        • 14.11.3 Product&Service Introduction

      • 14.12 Ono Pharmaceuticals

        • 14.12.1 Ono Pharmaceuticals Company Profile

        • 14.12.2 Ono Pharmaceuticals Overactive Bladder Market Performance

        • 14.12.3 Product&Service Introduction

      • 14.13 Mylan

        • 14.13.1 Mylan Company Profile

        • 14.13.2 Mylan Overactive Bladder Market Performance

        • 14.13.3 Product&Service Introduction

      • 14.14 Urigen Pharmaceuticals

        • 14.14.1 Urigen Pharmaceuticals Company Profile

        • 14.14.2 Urigen Pharmaceuticals Overactive Bladder Market Performance

        • 14.14.3 Product&Service Introduction

      • 14.15 Motif BioSciences

        • 14.15.1 Motif BioSciences Company Profile

        • 14.15.2 Motif BioSciences Overactive Bladder Market Performance

        • 14.15.3 Product&Service Introduction

      • 14.16 Sanofi

        • 14.16.1 Sanofi Company Profile

        • 14.16.2 Sanofi Overactive Bladder Market Performance

        • 14.16.3 Product&Service Introduction

      • 14.17 Recordati

        • 14.17.1 Recordati Company Profile

        • 14.17.2 Recordati Overactive Bladder Market Performance

        • 14.17.3 Product&Service Introduction

      • 14.18 Ion Channel Innovations

        • 14.18.1 Ion Channel Innovations Company Profile

        • 14.18.2 Ion Channel Innovations Overactive Bladder Market Performance

        • 14.18.3 Product&Service Introduction

      • 14.19 Addex Therapeutics

        • 14.19.1 Addex Therapeutics Company Profile

        • 14.19.2 Addex Therapeutics Overactive Bladder Market Performance

        • 14.19.3 Product&Service Introduction

      • 14.20 Auxilium Pharmaceuticals

        • 14.20.1 Auxilium Pharmaceuticals Company Profile

        • 14.20.2 Auxilium Pharmaceuticals Overactive Bladder Market Performance

        • 14.20.3 Product&Service Introduction

      • 14.21 FemmePharma

        • 14.21.1 FemmePharma Company Profile

        • 14.21.2 FemmePharma Overactive Bladder Market Performance

        • 14.21.3 Product&Service Introduction

      • 14.22 Kissei Pharma

        • 14.22.1 Kissei Pharma Company Profile

        • 14.22.2 Kissei Pharma Overactive Bladder Market Performance

        • 14.22.3 Product&Service Introduction

      • 14.23 Allergan

        • 14.23.1 Allergan Company Profile

        • 14.23.2 Allergan Overactive Bladder Market Performance

        • 14.23.3 Product&Service Introduction

      • 14.24 AltheRx Pharmaceuticals

        • 14.24.1 AltheRx Pharmaceuticals Company Profile

        • 14.24.2 AltheRx Pharmaceuticals Overactive Bladder Market Performance

        • 14.24.3 Product&Service Introduction

      • 14.25 Hydra Biosciences

        • 14.25.1 Hydra Biosciences Company Profile

        • 14.25.2 Hydra Biosciences Overactive Bladder Market Performance

        • 14.25.3 Product&Service Introduction

      • 14.26 Janssen

        • 14.26.1 Janssen Company Profile

        • 14.26.2 Janssen Overactive Bladder Market Performance

        • 14.26.3 Product&Service Introduction

      • 14.27 Antares Pharma

        • 14.27.1 Antares Pharma Company Profile

        • 14.27.2 Antares Pharma Overactive Bladder Market Performance

        • 14.27.3 Product&Service Introduction

      • 14.28 Pfizer

        • 14.28.1 Pfizer Company Profile

        • 14.28.2 Pfizer Overactive Bladder Market Performance

        • 14.28.3 Product&Service Introduction

      • 14.29 TheraVida

        • 14.29.1 TheraVida Company Profile

        • 14.29.2 TheraVida Overactive Bladder Market Performance

        • 14.29.3 Product&Service Introduction

      • 14.30 LG Life Sciences

        • 14.30.1 LG Life Sciences Company Profile

        • 14.30.2 LG Life Sciences Overactive Bladder Market Performance

        • 14.30.3 Product&Service Introduction

      • 14.31 Hisamitsu Pharmaceutical

        • 14.31.1 Hisamitsu Pharmaceutical Company Profile

        • 14.31.2 Hisamitsu Pharmaceutical Overactive Bladder Market Performance

        • 14.31.3 Product&Service Introduction

      • 14.32 Actavis

        • 14.32.1 Actavis Company Profile

        • 14.32.2 Actavis Overactive Bladder Market Performance

        • 14.32.3 Product&Service Introduction

      • 14.33 Toray Industries

        • 14.33.1 Toray Industries Company Profile

        • 14.33.2 Toray Industries Overactive Bladder Market Performance

        • 14.33.3 Product&Service Introduction

      • 14.34 Ipsen

        • 14.34.1 Ipsen Company Profile

        • 14.34.2 Ipsen Overactive Bladder Market Performance

        • 14.34.3 Product&Service Introduction

      • 14.35 Novartis

        • 14.35.1 Novartis Company Profile

        • 14.35.2 Novartis Overactive Bladder Market Performance

        • 14.35.3 Product&Service Introduction

      • 14.36 Teva Pharmaceutical

        • 14.36.1 Teva Pharmaceutical Company Profile

        • 14.36.2 Teva Pharmaceutical Overactive Bladder Market Performance

        • 14.36.3 Product&Service Introduction

      • 14.37 Takeda Pharmaceutical

        • 14.37.1 Takeda Pharmaceutical Company Profile

        • 14.37.2 Takeda Pharmaceutical Overactive Bladder Market Performance

        • 14.37.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Overactive Bladder Industry Research Conclusions

    • 15.2 Overactive Bladder Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Overactive Bladder Industry Market Size (2018-2029)

    • Figure China Overactive Bladder Production Volume, Production Value and Growth Rate of Type 1 (2018-2029)

    • Figure China Overactive Bladder Production Volume, Production Value and Growth Rate of Type 2 (2018-2029)

    • Figure China Overactive Bladder Production Volume, Production Value and Growth Rate of Type 3 (2018-2029)

    • Figure China Overactive Bladder Sales Volume, Sales Value and Growth Rate of Application 1 (2018-2029)

    • Figure China Overactive Bladder Sales Volume, Sales Value and Growth Rate of Application 2 (2018-2029)

    • Figure China Overactive Bladder Sales Volume, Sales Value and Growth Rate of Application 3 (2018-2029)

    • Figure North China Overactive Bladder Market Size and Growth Rate from 2018-2029

    • Figure Central China Overactive Bladder Market Size and Growth Rate from 2018-2029

    • Figure South China Overactive Bladder Market Size and Growth Rate from 2018-2029

    • Figure East China Overactive Bladder Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Overactive Bladder Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Overactive Bladder Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Overactive Bladder Market Size and Growth Rate from 2018-2029

    • Figure Overactive Bladder Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Overactive Bladder Market Share by Type in 2018

    • Figure China Overactive Bladder Market Share by Type in 2023

    • Figure China Overactive Bladder Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Overactive Bladder Production Volume and Growth Rate of Type 1 (2018-2023)

    • Figure China Overactive Bladder Production Volume and Growth Rate of Type 2 (2018-2023)

    • Figure China Overactive Bladder Production Volume and Growth Rate of Type 3 (2018-2023)

    • Figure China Overactive Bladder Market Share by Application in 2018

    • Figure China Overactive Bladder Market Share by Application in 2023

    • Figure China Overactive Bladder Total Market Size and Growth Rate from Consumption End

    • Figure China Overactive Bladder Market Size and Growth Rate of Application 1 (2018-2023)

    • Figure China Overactive Bladder Market Size and Growth Rate of Application 2 (2018-2023)

    • Figure China Overactive Bladder Market Size and Growth Rate of Application 3 (2018-2023)

    • Table China Overactive Bladder Production Volume by Region (2018-2023)

    • Table China Overactive Bladder Production Volume Share by Region (2018-2023)

    • Figure China Overactive Bladder Production Volume Share by Region (2018-2023)

    • Table China Overactive Bladder Production Value by Region (2018-2023)

    • Table China Overactive Bladder Production Value Share by Region (2018-2023)

    • Figure China Overactive Bladder Production Value Share by Region (2018-2023)

    • Table China Overactive Bladder Sales Volume by Region (2018-2023)

    • Table China Overactive Bladder Sales Volume Share by Region (2018-2023)

    • Figure China Overactive Bladder Sales Volume Share by Region (2018-2023)

    • Table China Overactive Bladder Sales Value by Region (2018-2023)

    • Table China Overactive Bladder Sales Value Share by Region (2018-2023)

    • Figure China Overactive Bladder Sales Value Share by Region (2018-2023)

    • Table North China Overactive Bladder Production Volume by Type (2018-2023)

    • Table North China Overactive Bladder Production Volume Share by Type (2018-2023)

    • Figure North China Overactive Bladder Production Volume Share by Type (2018-2023)

    • Table North China Overactive Bladder Sales Volume by Application (2018-2023)

    • Table North China Overactive Bladder Sales Volume Share by Application (2018-2023)

    • Figure North China Overactive Bladder Sales Volume Share by Application (2018-2023)

    • Table Central China Overactive Bladder Production Volume by Type (2018-2023)

    • Table Central China Overactive Bladder Production Volume Share by Type (2018-2023)

    • Figure Central China Overactive Bladder Production Volume Share by Type (2018-2023)

    • Table Central China Overactive Bladder Sales Volume by Application (2018-2023)

    • Table Central China Overactive Bladder Sales Volume Share by Application (2018-2023)

    • Figure Central China Overactive Bladder Sales Volume Share by Application (2018-2023)

    • Table South China Overactive Bladder Production Volume by Type (2018-2023)

    • Table South China Overactive Bladder Production Volume Share by Type (2018-2023)

    • Figure South China Overactive Bladder Production Volume Share by Type (2018-2023)

    • Table South China Overactive Bladder Sales Volume by Application (2018-2023)

    • Table South China Overactive Bladder Sales Volume Share by Application (2018-2023)

    • Figure South China Overactive Bladder Sales Volume Share by Application (2018-2023)

    • Table East China Overactive Bladder Production Volume by Type (2018-2023)

    • Table East China Overactive Bladder Production Volume Share by Type (2018-2023)

    • Figure East China Overactive Bladder Production Volume Share by Type (2018-2023)

    • Table East China Overactive Bladder Sales Volume by Application (2018-2023)

    • Table East China Overactive Bladder Sales Volume Share by Application (2018-2023)

    • Figure East China Overactive Bladder Sales Volume Share by Application (2018-2023)

    • Table Northeast China Overactive Bladder Production Volume by Type (2018-2023)

    • Table Northeast China Overactive Bladder Production Volume Share by Type (2018-2023)

    • Figure Northeast China Overactive Bladder Production Volume Share by Type (2018-2023)

    • Table Northeast China Overactive Bladder Sales Volume by Application (2018-2023)

    • Table Northeast China Overactive Bladder Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Overactive Bladder Sales Volume Share by Application (2018-2023)

    • Table Southwest China Overactive Bladder Production Volume by Type (2018-2023)

    • Table Southwest China Overactive Bladder Production Volume Share by Type (2018-2023)

    • Figure Southwest China Overactive Bladder Production Volume Share by Type (2018-2023)

    • Table Southwest China Overactive Bladder Sales Volume by Application (2018-2023)

    • Table Southwest China Overactive Bladder Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Overactive Bladder Sales Volume Share by Application (2018-2023)

    • Table Northwest China Overactive Bladder Production Volume by Type (2018-2023)

    • Table Northwest China Overactive Bladder Production Volume Share by Type (2018-2023)

    • Figure Northwest China Overactive Bladder Production Volume Share by Type (2018-2023)

    • Table Northwest China Overactive Bladder Sales Volume by Application (2018-2023)

    • Table Northwest China Overactive Bladder Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Overactive Bladder Sales Volume Share by Application (2018-2023)

    • Table Bayer Company Profile

    • Table Bayer Overactive Bladder Revenue, Price and Gross (2018-2023)

    • Table Laboratorios SALVAT Company Profile

    • Table Laboratorios SALVAT Overactive Bladder Revenue, Price and Gross (2018-2023)

    • Table Apogepha Arzneimittel Company Profile

    • Table Apogepha Arzneimittel Overactive Bladder Revenue, Price and Gross (2018-2023)

    • Table GlaxoSmithKline Company Profile

    • Table GlaxoSmithKline Overactive Bladder Revenue, Price and Gross (2018-2023)

    • Table Lipella Pharmaceuticals Company Profile

    • Table Lipella Pharmaceuticals Overactive Bladder Revenue, Price and Gross (2018-2023)

    • Table Ferring Pharmaceuticals Company Profile

    • Table Ferring Pharmaceuticals Overactive Bladder Revenue, Price and Gross (2018-2023)

    • Table Merck Company Profile

    • Table Merck Overactive Bladder Revenue, Price and Gross (2018-2023)

    • Table Kwang Dong Pharmaceutical Company Profile

    • Table Kwang Dong Pharmaceutical Overactive Bladder Revenue, Price and Gross (2018-2023)

    • Table TARIS BioMedical Company Profile

    • Table TARIS BioMedical Overactive Bladder Revenue, Price and Gross (2018-2023)

    • Table Elbion Company Profile

    • Table Elbion Overactive Bladder Revenue, Price and Gross (2018-2023)

    • Table Ranbaxy Laboratories Company Profile

    • Table Ranbaxy Laboratories Overactive Bladder Revenue, Price and Gross (2018-2023)

    • Table Ono Pharmaceuticals Company Profile

    • Table Ono Pharmaceuticals Overactive Bladder Revenue, Price and Gross (2018-2023)

    • Table Mylan Company Profile

    • Table Mylan Overactive Bladder Revenue, Price and Gross (2018-2023)

    • Table Urigen Pharmaceuticals Company Profile

    • Table Urigen Pharmaceuticals Overactive Bladder Revenue, Price and Gross (2018-2023)

    • Table Motif BioSciences Company Profile

    • Table Motif BioSciences Overactive Bladder Revenue, Price and Gross (2018-2023)

    • Table Sanofi Company Profile

    • Table Sanofi Overactive Bladder Revenue, Price and Gross (2018-2023)

    • Table Recordati Company Profile

    • Table Recordati Overactive Bladder Revenue, Price and Gross (2018-2023)

    • Table Ion Channel Innovations Company Profile

    • Table Ion Channel Innovations Overactive Bladder Revenue, Price and Gross (2018-2023)

    • Table Addex Therapeutics Company Profile

    • Table Addex Therapeutics Overactive Bladder Revenue, Price and Gross (2018-2023)

    • Table Auxilium Pharmaceuticals Company Profile

    • Table Auxilium Pharmaceuticals Overactive Bladder Revenue, Price and Gross (2018-2023)

    • Table FemmePharma Company Profile

    • Table FemmePharma Overactive Bladder Revenue, Price and Gross (2018-2023)

    • Table Kissei Pharma Company Profile

    • Table Kissei Pharma Overactive Bladder Revenue, Price and Gross (2018-2023)

    • Table Allergan Company Profile

    • Table Allergan Overactive Bladder Revenue, Price and Gross (2018-2023)

    • Table AltheRx Pharmaceuticals Company Profile

    • Table AltheRx Pharmaceuticals Overactive Bladder Revenue, Price and Gross (2018-2023)

    • Table Hydra Biosciences Company Profile

    • Table Hydra Biosciences Overactive Bladder Revenue, Price and Gross (2018-2023)

    • Table Janssen Company Profile

    • Table Janssen Overactive Bladder Revenue, Price and Gross (2018-2023)

    • Table Antares Pharma Company Profile

    • Table Antares Pharma Overactive Bladder Revenue, Price and Gross (2018-2023)

    • Table Pfizer Company Profile

    • Table Pfizer Overactive Bladder Revenue, Price and Gross (2018-2023)

    • Table TheraVida Company Profile

    • Table TheraVida Overactive Bladder Revenue, Price and Gross (2018-2023)

    • Table LG Life Sciences Company Profile

    • Table LG Life Sciences Overactive Bladder Revenue, Price and Gross (2018-2023)

    • Table Hisamitsu Pharmaceutical Company Profile

    • Table Hisamitsu Pharmaceutical Overactive Bladder Revenue, Price and Gross (2018-2023)

    • Table Actavis Company Profile

    • Table Actavis Overactive Bladder Revenue, Price and Gross (2018-2023)

    • Table Toray Industries Company Profile

    • Table Toray Industries Overactive Bladder Revenue, Price and Gross (2018-2023)

    • Table Ipsen Company Profile

    • Table Ipsen Overactive Bladder Revenue, Price and Gross (2018-2023)

    • Table Novartis Company Profile

    • Table Novartis Overactive Bladder Revenue, Price and Gross (2018-2023)

    • Table Teva Pharmaceutical Company Profile

    • Table Teva Pharmaceutical Overactive Bladder Revenue, Price and Gross (2018-2023)

    • Table Takeda Pharmaceutical Company Profile

    • Table Takeda Pharmaceutical Overactive Bladder Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US